mRS at three months | Hemorrhagic transformation | Duration of hospitalization | Death ≤ 7 days | |||||
---|---|---|---|---|---|---|---|---|
Estimate β (SE) | p | Estimate β (SE) | p | Estimate β (SE) | p | Estimate β (SE) | p | |
Age | −0.01 (0.1) | 0.9 | 0.02 (0.04) | 0.6 | 0.9 (0.7) | 0.2 | −0.03 (0.02) | 0.3 |
Male | −0.05 (0.05) | 0.9 | 0.03 (0.1) | 0.8 | 3.4 (2.5) | 0.2 | −0.1 (0.09) | 0.1 |
Hypercholesterolemia | −1.1 (0.4) | 0.009 | 0.003 (0.1) | 0.9 | −1.9 (2.6) | 0.5 | −0.2 (0.09) | 0.02 |
Statins | −1 (0.5) | 0.06 | −0.06 (0.1) | 0.7 | −0.1 (3) | 0.9 | −0.1 (0.1) | 0.3 |
Systolic blood pressure at baseline | −0.0004 (0.008) | 0.9 | −0.003 (0.002) | 0.2 | −0.0003 (0.05) | 0.9 | −0.003 (0.002) | 0.07 |
NIHSS at baseline | 0.08 (0.03) | 0.008 | 0.02 (0.009) | 0.01 | 0.2 (0.2) | 0.4 | 0.02 (0.006) | 0.002 |
NIHSS at 24 h | 0.09 (0.02) | <.001 | 0.03 (0.008) | 0.003 | 0.07 (0.2) | 0.7 | 0.03 (0.005) | <.001 |
Intracranial occlusion | 1.04 (0.4) | 0.01 | 0.4 (0.1) | 0.002 | 2.9 (2.5) | 0.2 | 0.03 (0.08) | 0.7 |
Thrombolysis | 0.2 (0.4) | 0.6 | 0.4 (0.1) | 0.002 | 2.7 (2.4) | 0.3 | 0.1 (0.08) | 0.2 |
Hemorrhagic transformation | 0.8 (0.4) | 0.04 | - | - | 2.3 (2.8) | 0.4 | 0.1 (0.09) | 0.1 |
Symptomatic intracranial hemorrhage | 1 (0.4) | 0.03 | - | - | −5.2 (6.4) | 0.4 | 0.6 (0.2) | <.001 |
Cardioembolic stroke subtype (AF) | 0.9 (0.4) | 0.053 | −0.03 (0.1) | 0.8 | 4.6 (2.5) | 0.07 | 0.07 (0.09) | 0.4 |
Large artery atherosclerosis stroke subtype | −0.09 (0.6) | 0.9 | −0.05 (0.2) | 0.8 | −4.8 (3.2) | 0.1 | −0.09 (0.1) | 0.4 |